Injections under the skin to heal scleroderma finger ulcers
Treatments studied
Part of Skin clinical trials.
This Phase 2 study tests whether injections under the skin can help heal painful, poor-circulation (ischemic) finger ulcers caused by scleroderma. It is for people whose ulcers have not improved with usual care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are age 18 or older and have systemic sclerosis (scleroderma)
- You have at least one active, painful finger ulcer from poor circulation that is not healing despite standard treatment for about 10 weeks
- The ulcer is on the finger past the first knuckle (near the nail is allowed) and is not from bone/calcified areas
- You should not be a current smoker, and you must not have stopped tobacco less than 3 months ago
- Your medicines must be stable or paused as required (especially hormone therapy, blood-vessel medicines, immune medicines, steroids, and antibiotics)
- You cannot have certain infections or serious heart/virus conditions, and you must be able to give written consent
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a cell-based treatment (mesenchymal stromal cells) to help heal painful finger/toe ulcers in people with systemic sclerosis. It is for ulcers that did not improve after a specific IV medicine called prostacyclins.
This trial tests if an enzyme called hyaluronidase can soften and improve the hard, tight skin on fingers caused by systemic sclerosis (scleroderma). It may help increase flexibility and comfort.
This trial tests a new cell injection treatment (RY_SW01) for people with systemic sclerosis (a condition causing skin thickening and organ issues). It aims to see if the therapy can improve skin hardening and overall symptoms.
This phase 1 trial tests a new cell therapy (89Zr-Oxine-RY_SW01) for people with diffuse scleroderma who have not responded well to at least two prior treatments. The goal is to see if this treatment is safe and could help control the disease.
This trial tests whether injecting a patient’s own regenerative cells under the skin helps heal diabetic foot ulcers. It also checks how safe the treatment is, especially when the ulcer is not caused by severe poor blood flow.
This study tests a new cream (TOP-N53) for digital ulcers caused by scleroderma. The cream is applied directly to the sore, and the goal is to see if it is safe and helps the ulcer heal.
Hear when a new Systemic Sclerosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.